Literature DB >> 14510167

P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.

D A Ndububa1, C M Yakicier, O S Ojo, O O Adeodu, O Rotimi, O Ogunbiyi, M Ozturk.   

Abstract

Mutations of p53 tumour suppressor gene often occur in hepatocellular carcinoma and, in particular, codon 249 hot-spot mutation is displayed by hepatocellular carcinomas occurring in hepatitis B virus-endemic areas with high dietary aflatoxin intake. This study was done to determine the frequency of p53 codon 249 mutation in hepato-cellular carcinoma in Nigerian patients with this tumour. Tumour samples were obtained from 18 Nigerian patients (all from the Southwest of the country) with histologically confirmed hepatocellular carcinoma by autopsy (n = 14), surgical resection (n = 3) and ante-mortem liver biopsy (n = 1). Fourteen of them had co-existing cirrhosis. Amplification of exon 7 of p53 gene from DNA samples of hepatocellular carcinoma tissue was undertaken by nested polymerase chain reaction followed by restriction enzyme analysis. One out of the 18 tumour samples tested (5.5%) demonstrated codon 249 mutation. This study suggests that, in Nigeria, especially the south-western region, aflatoxins appear to play a limited role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14510167

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  3 in total

Review 1.  The role of infections in the emergence of non-communicable diseases (NCDs): Compelling needs for novel strategies in the developing world.

Authors:  Dimie Ogoina; Geofrey C Onyemelukwe
Journal:  J Infect Public Health       Date:  2009-03-05       Impact factor: 3.718

Review 2.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

3.  Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.

Authors:  Abdel Raouf Abou El Azm; Mohamed Yousef; Raafat Salah; Wael Mayah; Salwa Tawfeek; Hussien Ghorabah; Nagwa Mansour
Journal:  Springerplus       Date:  2013-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.